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Abstract  
Hyperthermia treatment, generated by magnetic nanoparticles (MNPs) is promising since it is 
tumour-focused, minimally invasive and uniform. The most unique feature of magnetic 
nanoparticles is their reaction to and manipulation by a magnetic force which is responsible 
for enabling their potential as heating mediators for cancer therapy. With magnetic 
nanoparticle hyperthermia, a tumour is preferentially loaded with systemically administered 
nanoparticles with high-absorption cross section for transduction of an extrinsic energy source 
to heat. To maximize the energy deposited in the tumour while limiting the exposure in healthy 
tissues, the heating is achieved by exposing the region of tissue containing magnetic 
nanoparticles to an alternating magnetic field. The magnetic nanoparticles dissipate heat from 
relaxation losses thereby heating localized tissue above normal physiological ranges. Besides 
thermal efficiency, the biocompatibility of magnetite nanoparticles assists in their deployment 
as efficient drug carriers for targeted therapeutic regimes. In the present article we provide a 
state-of-the-art review focused on progress in nanoparticle induced hyperthermia treatments 
which have several potential advantages over both global and local hyperthermia treatments 
achieved without nanoparticles. Green bio-nanotechnology has attracted substantial attention 
and has demonstrable abilities to improve cancer therapy. Furthermore we have listed the 
challenges associated with this treatment along with future opportunities in this field which it 
is envisaged will be of interest to biomedical engineers, bio-materials scientists, medical 
researchers and pharmacological research groups. 
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1.INTRODUCTION  
In oncology, the term hyperthermia describes the treatment in which body tissue is exposed to 
high temperatures (up to 113oF), using an external energy source. Hyperthermia has a long 
history in the annals of cancer management. A correlation between erysipelas (a streptococcal 
skin infection) and tumour regression had been observed for over a century before William 
Coley in 1891 [1] first documented evidence of a relationship between infection and cancer 
regression in sarcoma patients. Ever-expanding research on the hyperthermic treatment of 
cancer has been sustained over the past four decades [1-12]. In some hyperthermia treatments, 
the patient’s blood is warmed up by an external device before it is re-transfused to the target 
volume (e.g. isolated limb perfusion and convective whole-body hyperthermia), and those 
utilizing contact heating (hyperthermic peritoneal and vesical perfusion) [19]. The different 
approaches are best categorized by the physical mode of power deposition (radiant vs. 
capacitive vs. convective), and their target volume (local vs. regional vs. whole-body 
hyperthermia).  
 
Locoregional hyperthermia can be differentiated into external, interstitial and endocavitary 
hyperthermia. Different heat delivery systems are available: antennae array, capacitive 
coupled devices and inductive devices. Depending on localization and size of the tumour 
diﬀerent methods and techniques can be applied: superficial, intratumoural (thermoablation), 
deep hyperthermia, endocavitary, and part-body hyperthermia. Randomized clinical trials 
have been performed mostly with electromagnetic applicators for superficial hyperthermia in 
combination with radiotherapy, deep hyperthermia, both in the presence and absence of  
radiation and endocavitary hyperthermia in combination with chemotherapy and radiotherapy. 
In randomized clinical trials it could be demonstrated, that loco-regional deep hyperthermia 
with antennae array or capacitive coupled hyperthermia devices may increase response rate, 
disease free survival and overall survival of patients with cancer in combination with 
radiotherapy or chemotherapy without increasing the toxicity of standard therapies. 
 
The heating sources are in general practice placed extra-corporally (external to the body) 
and locally illuminate the tumour region with electromagnetic waves (micro-waves or radio-
waves), provided that the tumour location in the respective organ is well located by 
corresponding imaging techniques (CT, MRI etc). In contrast, whole body hyperthermia is 
recommended when carcinomas with distant metastases are present. Wust et. al. [5] and latter 
on Hahn [20] and Deatsch & Evans [41] provided details on relevant hyperthermia techniques. 
 
Conductive heating techniques include cavitational water-heating, extra-corporal blood 
heating and RF needles [18]. The electric properties of each tissue are important in heat 
delivery methods. In contrast to the ex-vivo based measurements, Balidemaj et. al. [24] 
presented the in vivo conductivity of human muscle, bladder content and cervical tumours, 
acquired with magnetic resonance-based electric properties tomography (MR-EPT). The 
temperature-based optimisation was performed with patient models based on conductivity 
values. Their observations revealed that a higher conductivity in the bladder and in the muscle 
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tissue surrounding the tumour leads to higher power dissipation in the bladder and muscle, 
and therefore to lower tumour temperatures. 
 
The capacitive heating of tumours using a radiofrequency (RF) electric field is a method 
of hyperthermia, which is however unsuitable for site-specific hyperthermia since it does not 
allow specific heating of the tumours alone. In capacitive hyperthermia the normal tissue is 
also warmed in the zone connected to by an electrode. The specific adsorption rate of electric 
energy depends on electric resistance and permittivity of each tissue type. Since there are no 
significant differences in the electrical properties of tumour and normal tissues, it is difficult 
to specifically heat only the tumour. To protect the healthy tissue, mild heating is one option 
but this approach is often insufficient for treating tumours. To overcome this problem, 
magnetite cationic liposomes (MCLs) as fine magnetic particles of submicron size in inductive 
hyperthermia have been deployed by Kobayashi et. al. [9, 10]. MCLs were devised in order to 
improve adsorption by tumour cells and had a ten-fold higher affinity for tumour cells than 
fine magnetic particles with no electric charge. Kobayashi et. al. [11] demonstrated that 
magnetic nanoparticles serve as a medium that induces efficient heat generation in RF-
capacitive heating. In an in-vivo experiment, they observed that heat generation using 
magnetic nanoparticles was similar to that using inductive heating employing an alternating 
magnetic field.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Schematic diagram of hyperthermia treatment. 
 
Therefore with MCL injection, mild hyperthermia generates heat to raise the temperature 
greater than 108.5oF, required for cancer cell treatment. In contrast, other tissues that have not 
been injected with MCL do not experience an increase in temperature beyond 108:5oF even if 
picked up with an electrode. Therefore, magnetic nanoparticles are considered to be a 
promising heat-generating medium not only for inductive heating but also for capacitive 
hyperthermia [12]. 
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2. MAGNETIC NANOPARTICLE HYPERTHERMIA  
Hyperthermia has not yet been established in clinical routine due to the limitations of the 
currently available techniques with respect to selectively targeting the tumour region. 
Magnetic nanoparticle hyperthermia is promising in this regard and can treat the poorly 
accessible and deep-seated tumours. It has witnessed remarkable development from over two 
decades ago in 1993, when the group at Berlins Charite Hospital, headed by Andreas Jordan, 
initiated this field of magnetic fluid hyperthermia [27]. Significant improvement of this 
methodology has been achieved to date [29, 41, 45]. The schematic diagram in figure 1 
describes the trivial implementation of the magnetic nanoparticle hyperthermia treatment on 
easily accessible tumours. The concept behind Nanoparticle Hyperthermia Treatment (NPHT) 
is the MagForce Nanotherapy, which is appealing due to its efficient performance. The 
nanoparticles extract high energy per applied mass from a magnetic field. Due to their 
enormous surface [8] the nanoparticles are firstly able to carry a huge number of binding sites 
for cancer cells/target molecules and secondly able to intrude deeply into tumour tissue. With 
special coatings, the nanoparticles are delayed by the immune system and thus reach their 
targets. The nanoparticles can be ingested in great quantities by tumour cells and they can form 
a homogeneous fluid of low viscosity in water. They also demonstrate bio-compatability. The 
morphological properties of the nanoparticles, including their size, structure and shape are 
principally responsible for heat transmission. The nanoparticles are categorized as the multi-
domain (with size > 40 nm) and the single-domain particles (with radius << 20 nm). While 
using multi-domain nanoparticles, the heating is delivered by displacements of the domain 
wall i.e. via hysteresis losses. The single domain particles (often designated ‘super-
paramagnetic nanoparticles’), on the other hand, induce heating as result of energy loss 
processes during the re-orientation of the magnetisation in the magnetic field, or frictional 
losses where the nanoparticle is able to rotate in the surrounding medium, and have thus 
become commercially more attractive. Hergt et. al [21] discussed in detail the physical 
limitations of the nanoparticle hyperthermia treatment using magnetite fine particles. The 
specific absorption rate, which actually controls the heating of the tumour cells is defined as 
the heating potential of the nanoparticles (the amount of heating delivered per unit mass and 
time as a consequence of the exposure of the nanoparticles to an alternating magnetic field). 
This important parameter actually dictates the dosages which have to be applied to the tumour 
region, in order to achieve the inactivation of target cells. 
 
3.DIFFERENT TYPES OF NANOPARTICLES  
Different types of biocompatible nanoparticles have been used in the literature. Such particles 
are directly injected into the tumour tissue, where they are stimulated by an alternating 
magnetic field to produce heat due to Brownian and Neel (Nobel prize winner in physics in 
1970) relaxation processes. Iron-oxide nanoparticles are directly injected into the tumour and 
release heat after inductively-generated activation by an alternating magnetic field. 
Superparamagnetic iron oxide nanoparticles (SPIONs) also exhibit excellent biocompatibility 
in addition to multi-purpose biomedical potential. Iron oxides (either Fe3O4 or -Fe2O3) can be 
synthesized through the co-precipitation of Fe2+ and Fe3+ aqueous salt solutions by addition 
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of a base [14]. The control of size, shape and composition of nanoparticles depends on the 
type of salts used (e.g. chlorides, sulphates, nitrates, perchlorates, etc.), Fe2+ and Fe3+ ratio, pH 
and ionic strength of the media [14, 15]. Fortin et. al. [16] presented a comprehensive 
parametric study for the use of anionic colloidal nanocrystals to generate magnetically-induced 
hyperthermia. Folate-conjugated superpara-magnetic maghemite nanoparticles have been 
synthesized for the intracellular hyperthermia treatment of solid tumours and their qualitative 
and quantitative determinations have been conducted by Sonvico et. al. [17]. 
Gold nanoparticles have been extensively used in the literature for the hyperthermia 
treatment. Gold has high atomic number which enhances the effect of radio-therapy which is 
further induced by laser hypothermia. One of the recent developments is the use of colloidal 
solutions of bifunctional luminescent neodymium (Nd3+) ions doped -NaYF4 colloidal 
nanoparticles [22]. These particles may be excited in the visible or near infrared range. The 
infrared excitation is compatible with the windows of biological tissues and achieves sufficient 
penetration depths compared with either visible or UV-ranges. This characteristic is also 
coupled with long luminescence times (up to 150 s). Optimisation at 95oF was achieved in 25 
% Nd3+:NaYF4 solution. The work reported in [22] has the potential to develop therapeutic 
agents which could be deducted by molecular agents. Gold nanoparticles coated with 
biological agents permeate the tumour cells and localize with endosomes. The lower pH within 
the endosome allows an easy passage for the drug release into the target area.  
Magnetite cationic liposomes (MCLs), one of the groups of cationic magnetic particles, can 
be used as carriers to introduce magnetite nanoparticles into target cells since their positively 
charged surface interacts with the negatively charged cell surface; furthermore, they find 
applications in diverse hyperthermic treatments [9, 11, 13]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Superparamagnetic particles under the influence of an external magnetic field (left 
pannel), without the impact of magnetic field (right pannel). With permissions from chemicell 
GmbH [51]. 
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Figure 3: Ferromagnetic particles under the influence of an external magnetic field (left pan-
nel), without the impact of magnetic field (right pannel). With permissions from chemicell 
GmbH [51]. 
Magnetite nanoparticles conjugated with antibodies (antibody-conjugated magnetolipo-
somes, AMLs) have enabled tumour-specific contrast enhancement in MRI via systemic 
administration. Since magnetic nanoparticles are attracted to a high magnetic flux density, it 
is possible to manipulate cells labelled with magnetic nanoparticles using magnets. The re-
search group led by Kobayashi developed MCLs as mediators of intracellular hyperthermia. 
The cationic liposomes adopted by the research group [35] exhibited improved adsorption and 
incorporation into tumour cells, and had ten times higher affinity for tumour cells than 
neutrally-charged magnetoliposomes [9]. The applications of these functionalized magnetic 
nanoparticles with their unique features will further improve medical techniques. 
 
Carbon or polymeric nanoparticles labelled with fluorine-18 deoxyglucose have been 
studied in pre-clinical models to enhance tumour diagnosis and detection rates using positron 
emission tomography [26, 25]. Single walled carbon nanotubes (SWNTs) have a wide 
dynamic range of electromagnetic absorptions that arise from their one-dimensional structure 
which consists of a honeycomb pattern of carbon that is rolled into a seamless cylinder forming 
a thin cylindrical form of carbon. The conductivity of carbon nanotubes is determined by the 
crystalline arrangement of carbon of the cylindrical wall. Nanotubes are either metallic or 
semiconducting depending on the twist in the graphitic carbon wall. The absorption 
characteristics of carbon nanotubes have been utilized as hyperthermic enhancers using NIR 
absorptions by Kam et. al. [30]. The synthesis of the above-mentioned magnetic nanoparti-
cles (MNPs) has attracted much attention during the last few years and a list of efficient routes 
to attain shape-controlled and highly stable magnetic nanoparticles with narrow size 
distribution has been recently reported by Majidi [31]. Several popular methods including co-
precipitation, micro-emulsion, thermal decomposition, solvothermal, sonochemical, 
microwave-assisted, chemical vapour deposition, combustion, carbon arc, and laser pyrolysis, 
for the synthesis of magnetic nanoparticles have been discussed with detailed references. 
Figure 4 describes different routes for the synthesis of silver nanoparticles (AgNP). 
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                             Figure 4: Different routes to synthesis of nanoparticles 
 
 
Green nanotechnology has also stimulated considerable attention and includes various 
processes which reduced toxicity. The biosynthesis of metal nanoparticles by plants is 
currently under development. Biological methods of nanoparticle preparation using micro-
organisms, enzymes, fungi and plants or plant extracts are several possible substitutes to 
chemical and physical methods. Considerable progress in this direction has been made and 
summarised by Majidi [31], Iravani [32], Yew et. al. [33] and the references listed therein. 
Green synthesis has many advantageous features for the fabrication of magnetic nanoparticles. 
 
4. EXPERIMENTAL/THEORETICAL MODELLING STUDIES OF MAGNETIC 
NANOPARTICLE HYPERTHERMIA  
Controlling both the heat distribution and temperature elevations is an immense challenge 
in clinical applications of magnetic nanoparticle hyperthermia. Researchers from the USA [36] 
have evaluated the magnetic nanofluid transport and heat distribution induced by 
commercially available magnetic nanoparticles injected into the extracellular space of 
biological tissue using agarose gel with porous structures similar to human tissue. The 
nanofluid distributions in the gel were examined via digital imaging of the nanofluid spreading 
in the gel. A radio-frequency electromagnetic field was applied to the gel and thus the 
nanofluid injection and the initial rates of temperature rise at various locations were measured 
to obtain the specific absorption rate (SAR) distribution. This experimental study provided a 
benchmark towards providing guidance for designing better treatment protocol for future 
improved hyperthermia treatments. In 2007 the group headed by Jordan [49] reported the 
results of the first study into the feasibility of magnetic fluid hyperthermia in human patients. 
Their study involved 14 patients receiving treatment for a particularly severe type of brain 
cancer, recurrent “glioblastomamultiforme”, via a combination of fractionated external beam 
radiotherapy and several sessions of thermotherapy. Thermotherapy was eﬀected by heat 
generated from aminosilane coated iron oxide nanoparticles that had been injected into 
multiple sites throughout each tumour. The choice of injection sites was based on data from a 
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comprehensive series of MRI scans of the cranium coupled with a specially developed 
software planning system (NanoPlan). The superparamagnetic iron oxide nanoparticles (core 
size 15 nm) were dis-persed in water at a concentration of 112 mgFe ml. Each tumour was 
injected with from 0.1 to 0.7 ml of the magnetic fluid per ml of tumour and then exposed to a 
magnetic field of 3.8 to 13.5 kAm1 alternating at 100 kHz. The study successfully 
demonstrated that this form of thermotherapy using magnetic nanoparticles could be safely 
applied to the treatment of brain tumours and that hyperthermic temperatures could be 
achieved. Very small deposits (0.1 ml) of the magnetic fluid could be precisely deposited 
within the targeted area. Follow-up CT scans and reproducible temperature measurements 
confirmed that these deposits were stable over several weeks. Patient survival and local tumour 
control were not considered primary endpoints of this study, however, clinical outcomes were 
observed to be promising with the therapy being well tolerated by all patients. More complete 
evaluation of clinical outcomes is to be assessed in a phase II study on 65 patients with 
recurrent glioblastoma multiforme. Later on, the research group headed by Jordan applied their 
methodology for the treatment of prostate cancer [28, 37]. An overview on their findings is 
provided in Table 1. 
Considerable efforts have also been made in recent years to optimize material properties 
for magnetic hyperthermia applications [46, 47]. Due to the complexity of the problem, several 
aspects pertaining to the combined influence of different parameters such as those associated 
with the geometry, concentration and absorption rate of the nanoparticles and the period of 
thermal ablation of tumour cells, are still unclear. Recently, Verde [50] et. al discussed in 
detail the role of the magnetic anisotropy on the specific absorption rate of cobalt-ferrite 
nanoparticles with diameters < 14nm. They demonstrated that the anisotropy is in fact a prime 
parameter in the search for materials optimized for magnetic hyperthermia. X-ray diffraction 
was used for carrying out the structural characterization. The relevant magnetic parameters 
were extracted from vibrating sample magnetometry. Hyperthermia investigations were 
performed at 500 kHz with a sinusoidal magnetic field. The specific absorption rate was 
investigated as a function of the coercive field, saturation magnetization, particle size, and 
magnetic anisotropy. The theoretical predictions from the linear response theory and dynamic 
hysteresis simulations were validated by experimental findings achieving close agreement in 
both cases. 
 
Superparamagnetism is a form of magnetism, which appears in small ferromagnetic or 
ferrimagnetic nanoparticles. Deep understanding of magnetic relaxation phenomena of the 
superparamagnetic iron oxide nanoparticles (SPIONs) has become a challenge due to their 
importance in pharmaceutical and industrial communities. The precise control of the 
physiochemical properties of these magnetic systems is crucial for hyperthermia applications, 
as the induced heat is highly dependent on such properties. Jordan et. al. [48] discussed in 
detail the limitations and recent advances in the development of superparamagnetic iron oxide 
nanoparticles for hyperthermia. Egli [47] provided a useful comparison for the analysis of 
SPIONs and provided a self-consistency check of existing theories on magnetic relaxation 
phenomena using the susceptibility inversion. The physical, magnetic and heating 
characteristics of magnetite nanoparticle suspensions with average diameters of 12.5 and 15.7 
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nm were discussed in detail by Suto et. al [53]. They highlighted the relative contributions of 
Neel and Brownian relaxations on magnetic heat dissipation and reported that the specific 
absorption rates (SAR) dropped by 27% for the 12.5 nm particles and by 67% for the 15.7 nm 
particles, by suppressing the particle rotation (via dispersion of magnetite nanoparticles in 
hydro-gel). 
 
Recently a research group led by Sinibaldi [44] provided a quantitative framework to 
demonstrate nanofluid infusion and the subsequent thermal activation of the infused 
nanoparticles for hyperthermia treatment. A simplified analytical technique was adopted to 
predict the nanoparticles concentration profile during the infusion process. The concentration 
profile was then exploited to depict the steady-state temperature profile. Despite the 
simplifications introduced to enable the analytical derivations, their research group claimed to 
take into account physically relevant aspects including tissue heterogeneity, poroelasticity, 
blood perfusion and nanoparticle absorption onto tissue. They obtained optimal working 
curves which could be effectively used for planning real procedures. Another study conducted 
by the same group provided an analytical expression for the time-dependent nanoparticle 
concentration during the infusion into poroelastic brain tissue, which also accounts for particle 
binding onto cells [45]. The role of the involved physical aspects was considered including 
the tissue poroelasticity, infusion parameters and nanoparticles physico-chemical properties. 
Their model was validated by considering the clinically relevant ranges for the infusion 
parameters. The research group led by Bellizzi [54]  presented the optimisation criterion for 
the choice of magnetic nanoparticle hyperthermia conditions and later provided the numerical 
assessment with reference to the challenging and clinically relevant case of brain tumours, by 
using a 3D model of the human head [55]. The two important features of their study were the 
minimised magnetic nanoparticles dosage and the controlled temperature rise to enable 
efficient and safer treatment. Their findings further confirmed that when a magnetic field with 
high amplitude is used, the most efficient magnetic nanoparticles are those with multi-domain 
core. A number of seminal investigations from the past three decade have been documented 
in Table 1, along with the nanoprticle type, size, coating, advancement and the drawbacks of 
the study. 
 
5. CONCLUSIONS  
A small rise in tumour temperature with magnetic nanoparticle hyperthermia makes cancer 
cells more susceptible to radiation and chemotherapy. The means of achieving this is not 
trivial, and traditional methods have certain drawbacks. Loading tumours with systematically 
administered energy-transducing nanoparticles can circumvent several of the obstacles to 
achieve tumour hyperthermia. However, nanoparticles also face unique challenges prior to 
clinical implementation. This article has summarized the current technologies and described 
the advantages and challenges of magnetic nanoparticle hyperthermia studies. Infusion 
duration and flow rate, nanoparticle concentration in the nanofluid, magnetic field intensity 
and frequency have been identified as the controlling parameters of this challenging treatment. 
Researchers from different parts of the world are trying to provide generalized criteria which 
could significantly improve the magnetic nanoparticle hyperthermia performance, by reducing 
the required magnetic nanoparticle dosage and enabling, at the same time, a complete planning 
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of the temperature rise of the exposed tissue. The 21st century will inevitably witness continued 
expansion in magnetic nanoparticle hyperthermia research. 
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